MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:12 Uhr</div>[url=https://www.instagram.com/zoyamonros/ ]Zoya Demidenko[/url]: Scientist in Cancer Biology [url=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P ]Zoya Demidenko[/url] is a recognized scientist affiliated with the Unit of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she worked at the NIH and New York Medical College, establishing a solid base in biomedical research. Demidenko's scholarly contributions spans multiple pivotal areas, encompassing the PI3K/AKT/mTOR molecular pathway, cellular cycle regulation, cell senescence, and malignancy science. As of now, she has written more than 46 academic papers, which have received more than 4,100 citations — a indicator to the influence of her work. Among her key achievements concerns elucidating the pathways of cellular senescence. Her studies demonstrated that when the cellular division cycle is arrested yet cellular expansion proceeds, cells undergo senescence. Importantly, [url=https://www.instagram.com/hibou_sova/ ]Zoya Demidenko[/url] established that this process can be inhibited by medication using agents such as mTOR inhibitors. [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey= ]Zoya Demidenko[/url] has furthermore contributed greatly to oncological therapy research, notably in the field of selective cell protection — a strategy aimed at shielding non-cancerous tissue from chemotherapy whilst leaving malignant cells susceptible. This approach offers major hope for lowering the adverse effects of cancer treatment. Across her scientific life, Demidenko has worked with top investigators worldwide, such as Dr. Mikhail Blagosklonny. Her work appears in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Holding an h-index of 33, [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126 ]Zoya Demidenko[/url] is recognized as a highly impactful contributor in contemporary oncological science, with her findings keep to influence our comprehension of how cells grow old, interact with therapy, and the ways in which cancer might be more effectively targeted. https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey= </blockquote><br> Abbrechen
